title: Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
authors.forename: Marcin
authors.initials: M
authors.lastname: Renke
authors.forename: Leszek
authors.initials: L
authors.lastname: Tylicki
authors.forename: Narcyz
authors.initials: N
authors.lastname: Knap
authors.forename: Przemyslaw
authors.initials: P
authors.lastname: Rutkowski
authors.forename: Alexander
authors.initials: A
authors.lastname: Neuwelt
authors.forename: Wojciech
authors.initials: W
authors.lastname: Larczynski
authors.forename: Michal
authors.initials: M
authors.lastname: Wozniak
authors.forename: Boleslaw
authors.initials: B
authors.lastname: Rutkowski
mesh_terms: D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000975:Antioxidants / Q000494:pharmacology*; D001562:Benzimidazoles / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D002908:Chronic Disease; D017315:Cilazapril / Q000627:therapeutic use; D003404:Creatinine / Q000652:urine; D018592:Cross-Over Studies; D015237:Dinoprost / Q000031:analogs & derivatives / Q000652:urine; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy / Q000503:physiopathology* / Q000652:urine; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D013148:Spironolactone / Q000494:pharmacology*; D000077333:Telmisartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D001562:Benzimidazoles; D001565:Benzoates; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D006852:Hydrochlorothiazide; D017315:Cilazapril; C075750:8-epi-prostaglandin F2alpha; D013148:Spironolactone; D003404:Creatinine; D015237:Dinoprost; D000077333:Telmisartan